194 related articles for article (PubMed ID: 31407531)
1. Genome-wide meta-analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans.
Do AN; Zhao W; Baldridge AS; Raffield LM; Wiggins KL; Shah SJ; Aslibekyan S; Tiwari HK; Limdi N; Zhi D; Sitlani CM; Taylor KD; Psaty BM; Sotoodehnia N; Brody JA; Rasmussen-Torvik LJ; Lloyd-Jones D; Lange LA; Wilson JG; Smith JA; Kardia SLR; Mosley TH; Vasan RS; Arnett DK; Irvin MR
Mol Genet Genomic Med; 2019 Oct; 7(10):e00788. PubMed ID: 31407531
[TBL] [Abstract][Full Text] [Related]
2. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
4. Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
McDonough CW; Warren HR; Jack JR; Motsinger-Reif AA; Armstrong ND; Bis JC; House JS; Singh S; El Rouby NM; Gong Y; Mychaleckyj JC; Rotroff DM; Benavente OR; Caulfield MJ; Doria A; Pepine CJ; Psaty BM; Glorioso V; Glorioso N; Hiltunen TP; Kontula KK; Arnett DK; Buse JB; Irvin MR; Johnson JA; Munroe PB; Wagner MJ; Cooper-DeHoff RM
Clin Pharmacol Ther; 2021 Sep; 110(3):723-732. PubMed ID: 34231218
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry.
Irvin MR; Sitlani CM; Noordam R; Avery CL; Bis JC; Floyd JS; Li J; Limdi NA; Srinivasasainagendra V; Stewart J; de Mutsert R; Mook-Kanamori DO; Lipovich L; Kleinbrink EL; Smith A; Bartz TM; Whitsel EA; Uitterlinden AG; Wiggins KL; Wilson JG; Zhi D; Stricker BH; Rotter JI; Arnett DK; Psaty BM; Lange LA
Pharmacogenomics J; 2019 Feb; 19(1):97-108. PubMed ID: 29855607
[TBL] [Abstract][Full Text] [Related]
6. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
[TBL] [Abstract][Full Text] [Related]
7. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
Schmieder RE; Martus P; Klingbeil A
JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
[TBL] [Abstract][Full Text] [Related]
8. Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
Singh S; McDonough CW; Gong Y; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
Sci Rep; 2019 Nov; 9(1):17323. PubMed ID: 31754133
[TBL] [Abstract][Full Text] [Related]
9. Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium.
Bis JC; Sitlani C; Irvin R; Avery CL; Smith AV; Sun F; Evans DS; Musani SK; Li X; Trompet S; Krijthe BP; Harris TB; Quibrera PM; Brody JA; Demissie S; Davis BR; Wiggins KL; Tranah GJ; Lange LA; Sotoodehnia N; Stott DJ; Franco OH; Launer LJ; Stürmer T; Taylor KD; Cupples LA; Eckfeldt JH; Smith NL; Liu Y; Wilson JG; Heckbert SR; Buckley BM; Ikram MA; Boerwinkle E; Chen YD; de Craen AJ; Uitterlinden AG; Rotter JI; Ford I; Hofman A; Sattar N; Slagboom PE; Westendorp RG; Gudnason V; Vasan RS; Lumley T; Cummings SR; Taylor HA; Post W; Jukema JW; Stricker BH; Whitsel EA; Psaty BM; Arnett D
PLoS One; 2015; 10(10):e0140496. PubMed ID: 26516778
[TBL] [Abstract][Full Text] [Related]
10. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
11. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
[TBL] [Abstract][Full Text] [Related]
12. The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.
Do AN; Lynch AI; Claas SA; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Tiwari HK; Arnett DK; Irvin MR
J Hum Hypertens; 2016 Sep; 30(9):549-54. PubMed ID: 26791477
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy--a meta-analysis.
Dahlöf B; Pennert K; Hansson L
Clin Exp Hypertens A; 1992; 14(1-2):173-80. PubMed ID: 1347256
[TBL] [Abstract][Full Text] [Related]
14. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
[TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
[TBL] [Abstract][Full Text] [Related]
16. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies.
Wiens M; Etminan M; Gill SS; Takkouche B
J Intern Med; 2006 Oct; 260(4):350-62. PubMed ID: 16961672
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study.
Di Bari M; van de Poll-Franse LV; Onder G; Kritchevsky SB; Newman A; Harris TB; Williamson JD; Marchionni N; Pahor M;
J Am Geriatr Soc; 2004 Jun; 52(6):961-6. PubMed ID: 15161462
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
J Am Heart Assoc; 2022 Dec; 11(24):e026789. PubMed ID: 36515246
[TBL] [Abstract][Full Text] [Related]
19. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
Siegel D; Lopez J; Meier J; Cunningham F
Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
[TBL] [Abstract][Full Text] [Related]
20. Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.
Omboni S; Kario K; Bakris G; Parati G
J Hypertens; 2018 Apr; 36(4):720-733. PubMed ID: 29045341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
